Curvebeam Ai Ltd
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot … Read more
Market Cap & Net Worth: Curvebeam Ai Ltd (CVB)
Curvebeam Ai Ltd (AU:CVB) has a market capitalization of $17.16 Million (AU$27.71 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27934 globally and #700 in its home market, demonstrating a -6.45% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Curvebeam Ai Ltd's stock price AU$0.06 by its total outstanding shares 477734297 (477.73 Million).
Curvebeam Ai Ltd Market Cap History: 2023 to 2026
Curvebeam Ai Ltd's market capitalization history from 2023 to 2026. Data shows change from $122.76 Million to $17.16 Million (-49.79% CAGR).
Curvebeam Ai Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Curvebeam Ai Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.81x
Curvebeam Ai Ltd's market cap is 1.81 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $122.76 Million | $8.06 Million | -$52.05 Million | 15.24x | N/A |
| 2024 | $39.93 Million | $6.53 Million | -$23.10 Million | 6.12x | N/A |
| 2025 | $21.89 Million | $12.10 Million | -$16.84 Million | 1.81x | N/A |
Competitor Companies of CVB by Market Capitalization
Companies near Curvebeam Ai Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Curvebeam Ai Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Curvebeam Ai Ltd Historical Marketcap From 2023 to 2026
Between 2023 and today, Curvebeam Ai Ltd's market cap moved from $122.76 Million to $ 17.16 Million, with a yearly change of -49.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$17.16 Million | -21.62% |
| 2025 | AU$21.89 Million | -45.19% |
| 2024 | AU$39.93 Million | -67.47% |
| 2023 | AU$122.76 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Curvebeam Ai Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.16 Million USD |
| MoneyControl | $17.16 Million USD |
| MarketWatch | $17.16 Million USD |
| marketcap.company | $17.16 Million USD |
| Reuters | $17.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.